TechnoMark News

Biosimilars market was estimated to be over US$ 4,500 Mn in 2018. It is anticipated to grow at a CAGR of 31.4% from 2019 to 2030. The growth of the biosimilars market can be attributed to factors such as the increasing demand for biosimilar drugs due to their cost-effectiveness and rising incidence of chronic diseases, which have led to wide-scale adoption of these products worldwide. To obtain better insights regarding the market scenario, prominent players are increasingly focusing on collaborative initiatives with several institutes and research centers. For instance, PlantForm Corporationhas signed an agreement with the University of Guelph Canada to enhance research studies in the field of biosimilars and develop new ones. Major Key Players of the Biosimilars Market are: Pfizer, Sandoz International, Teva Pharmaceuticals, Amgen, Biocon, Dr. Reddy’s Laboratories, Celltrion, Samsung Biologics, Stada Arzneimittel AG and Mylan. Read More @  https://www.medgadget.com/2020/11/biosim...

Global biosimilars market report gives comprehensive outlook on biosimilars products across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on biosimilars market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application, manufacturing type, distribution channel, and geographic regions. Global biosimilars market estimated to be valued US$ 4.10 Bn in 2018 and poised to grow at CAGR of 23.0% over 2019-2025. Market for biosimilars projected to reach US$ 14.23 Bn by 2025 owing to increasing patent expires of biologics and rising biosimilars product pipeline. Major Key Players of the  Biosimilars  Market are: Amgen Inc. (U.S.), Biocon Ltd. (India), Celltrion, Inc. (South Korea), Dr Reddy’s Laboratories Ltd. (India), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer Inc. (U.S.), Samsung Bioepis (South Korea), Novartis AG (Switzerland), Te...